Chronic lymphocytic leukaemia vaccine

N/A

Report date: 2024/10/18 20:00:35

Base Information

Drug NameChronic lymphocytic leukaemia vaccine
Drug Alias NameATCEVATCE vaccineOncoquest-CLL
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionNatural killer cells stimulantsCytotoxic T lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXeme Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXeme Biopharma Inc
Active IndicationsN/A
Inactive IndicationsLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A